Submitted by Anonymous (not verified) on 23 January 2026 - 16:55
Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Withdrawn
Source:
Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Withdrawn